Thermo Fisher Boosts Invitrogen SuperScript V Reverse Transcriptase to Room‑Temperature Stability with Biomatter
Thermo Fisher’s upgraded Invitrogen SuperScript V reverse transcriptase, now oxidation‑resistant and room‑temperature stable thanks to a Biomatter partnership, cuts cold‑chain costs, boosts reliability for mRNA and diagnostic research, and supports …
- THERMO FISHER SCIENTIFIC INC
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read


